Institutional & Family Asset Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-11
| Closed | -$236 | – | 739 |
|
|
2023
Q4 | $236 | Hold |
11
| – | – | ﹤0.01% | 689 |
|
|
2023
Q3 | $227 | Hold |
11
| – | – | ﹤0.01% | 696 |
|
|
2023
Q2 | $325 | Hold |
11
| – | – | ﹤0.01% | 712 |
|
|
2023
Q1 | $253 | Hold |
11
| – | – | ﹤0.01% | 703 |
|
|
2022
Q4 | $306 | Buy |
11
+5
| +83% | +$139 | ﹤0.01% | 684 |
|
|
2022
Q3 | $0 | Hold |
6
| – | – | ﹤0.01% | 718 |
|
|
2022
Q2 | $0 | Hold |
6
| – | – | ﹤0.01% | 735 |
|
|
2022
Q1 | $0 | Buy |
+6
| New | – | ﹤0.01% | 787 |
|
|
2021
Q4 | – | Sell |
-6
| Closed | – | – | 830 |
|
|
2021
Q3 | $0 | Sell |
6
-4
| -40% | – | ﹤0.01% | 918 |
|
|
2021
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 879 |
|
|
2021
Q1 | $1K | Sell |
10
-6
| -38% | -$600 | ﹤0.01% | 852 |
|
|
2020
Q4 | $1K | Buy |
+16
| New | +$1K | ﹤0.01% | 828 |
|